Prevalence of Escherichia coli sequence type 131 and its H30 subclone among E. coli isolates in a French hospital

International Journal of Antimicrobial Agents

Volumn 44, Issue 5, 2014, Pages 466-468

  Lafolie, Jeremy ^a   Nicolas Chanoine, Marie Hélène ^b,c,d   Grenouillet, Frédéric ^a   Hocquet, Didier ^a,e   Bertrand, Xavier ^a,e  

^a UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^b BEAUJON HOSPITAL   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d CENTRE DE RECHERCHE SUR L INFLAMMATION   (France)

^e UNIVERSITY HOSPITAL OF BESANÇON   (France)

Author keywords

Clonal expansion; ESBL; MLST; Multidrug resistance; Phylogenetic analysis

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; AMOXICILLIN PLUS CLAVULANIC ACID; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; ERTAPENEM; IMIPENEM; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ANTIINFECTIVE AGENT; BETA LACTAMASE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CLONE; CONTROLLED STUDY; ESCHERICHIA COLI; ESCHERICHIA COLI H30; ESCHERICHIA COLI SEQUENCE TYPE 131; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; NONHUMAN; PHENOTYPE; STRAIN DIFFERENCE; UNIVERSITY HOSPITAL; WILD TYPE; CLASSIFICATION; DRUG EFFECTS; ESCHERICHIA COLI INFECTIONS; FRANCE; GENETICS; GENOTYPE; ISOLATION AND PURIFICATION; MICROBIOLOGY; MULTILOCUS SEQUENCE TYPING; PREVALENCE; RETROSPECTIVE STUDY; SECRETION (PROCESS);

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FRANCE; GENOTYPE; HOSPITALS, UNIVERSITY; MULTILOCUS SEQUENCE TYPING; PREVALENCE; RETROSPECTIVE STUDIES;

EID: 84908394401     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2014.07.016     Document Type: Article

References (14)

1. M.H. Nicolas-Chanoine, J. Blanco, V. Leflon-Guibout, R. Demarty, M.P. Alonso, and M.M. Canica Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15 J Antimicrob Chemother 61 2008 273 281
2. M.H. Nicolas-Chanoine, X. Bertrand, and J.Y. Madec Escherichia coli ST131, an intriguing clonal group Clin Microbiol Rev 27 2014 543 574
3. L.B. Price, J.R. Johnson, M. Aziz, C. Clabots, B. Johnston, and V. Tchesnokova The epidemic of extended-spectrum-β-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx mBio 4 2013 e00377 e413
4. A. Colpan, B. Johnston, S. Porter, C. Clabots, R. Anway, and L. Thao Escherichia coli sequence type 131 (ST131) subclone H30 as an emergent multidrug-resistant pathogen among US veterans Clin Infect Dis 57 2013 1256 1265
5. R. Banerjee, A. Robicsek, M.A. Kuskowski, S. Porter, B.D. Johnston, and E. Sokurenko Molecular epidemiology of Escherichia coli sequence type 131 and its H30 and H30-Rx subclones among extended-spectrum-β-lactamase-positive and -negative E. coli clinical isolates from the Chicago region, 2007 to 2010 Antimicrob Agents Chemother 57 2013 6385 6388
6. R. Banerjee, B. Johnston, C. Lohse, S. Chattopadhyay, V. Tchesnokova, and E.V. Sokurenko The clonal distribution and diversity of extraintestinal Escherichia coli isolates vary according to patient characteristics Antimicrob Agents Chemother 57 2013 5912 5917
7. G. Peirano, A.K. van der Bij, J.L. Freeman, L. Poirel, P. Nordmann, and M. Costello Characteristics of Escherichia coli sequence type 131 isolates that produce extended-spectrum β-lactamases: global distribution of the H30-Rx sublineage Antimicrob Agents Chemother 58 2014 3762 3767
8. J. Blanco, A. Mora, R. Mamani, C. López, M. Blanco, and G. Dahbi Spanish Group for Nosocomial Infections (GEIH). Four main virotypes among extended-spectrum-β-lactamase-producing isolates of Escherichia coli O25b:H4-B2-ST131: bacterial, epidemiological, and clinical characteristics J Clin Microbiol 51 2013 3358 3367
9. H. Dhanji, M. Doumith, O. Clermont, E. Denamur, R. Hope, and D.M. Livermore Real-time PCR for detection of the O25b-ST131 clone of Escherichia coli and its CTX-M-15-like extended-spectrum β-lactamases Int J Antimicrob Agents 36 2010 355 358
10. C. Horner, W. Fawley, K. Morris, P. Parnell, M. Denton, and M. Wilcox Escherichia coli bacteraemia: 2 years of prospective regional surveillance (2010-12) J Antimicrob Chemother 69 2014 91 100
11. S. Adams-Sapper, B.A. Diep, F. Perdreau-Remington, and L.W. Riley Clonal composition and community clustering of drug-susceptible and -resistant Escherichia coli isolates from bloodstream infections Antimicrob Agents Chemother 57 2013 490 497
12. D.A. Williamson, J.T. Freeman, S. Porter, S. Roberts, S. Wiles, and D.L. Paterson Clinical and molecular correlates of virulence in Escherichia coli causing bloodstream infection following transrectal ultrasound-guided (TRUS) prostate biopsy J Antimicrob Chemother 68 2013 2898 2906
13. F. Bert, J.R. Johnson, B. Ouattara, V. Leflon-Guibout, B. Johnston, and E. Marcon Genetic diversity and virulence profiles of Escherichia coli isolates causing spontaneous bacterial peritonitis and bacteremia in patients with cirrhosis J Clin Microbiol 48 2010 2709 2714
14. C. Brechet, J. Plantin, M. Sauget, M. Thouverez, D. Talon, and P. Cholley Wastewater treatment plants release large amounts of extended-spectrum β-lactamase-producing Escherichia coli into the environment Clin Infect Dis 58 2014 1658 1665